Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THRIVE-AAJP deuruxolitinib in severe alopecia areata
jRCT2031260062Recruiting
- Sponsor
- Sun Pharma
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in alopecia areata comparing Deuruxolitinib arm with Placebo then deuruxolitinib arm (2 arms). Started Jun 2026; status: recruiting.
02
Drugs
deuruxolitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on jRCT2031260062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260062.